Studies have shown that supplementing with vitamin A in MS patients can significantly regulate the expression of RA receptor (RAR) genes, especially by down‐regulating RAR‐α and up‐regulating RAR‐γ (Bitarafan et al. 2013). Here, RARA is linked to myeloid sarcoma.